Cingulate Presents Data For Its Triple Release Buspirone Product Candidate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

19.09.2022 - Data Demonstrated Ability of CTx-2103 to Deliver a Single Administration of Triple-Release Buspirone – Setting the Stage for Future Trials Employing Cingulate’s Precision Timed Release (PTR) Technology CTx-2103 has the Potential to be the First . Seite 1

United statesMatthew bramsPsych congressCingulate incPrecision timed releaseNew orleansChief medical officerCingulate presents data for its triple release buspirone product candidate